Total number of publications acknowledging CRC1425 funding and/or membership: 173
Average Impact Factor: 10.32
How to acknowledge CRC1425 funding/membership:
For work by Members not directly CRC-funded (optional):
Joe Blogs is a member of SFB1425, funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project #422681845.
For CRC-funded research (obligatory):
This study was part of SFB1425, funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – Project #422681845.
Fan X, Cyganek L, Nitschke K, Uhlig S, Nuhn P, Bieback K, Duerschmied D, El-Battrawy I, Zhou X, Akin I. Functional Characterization of Human Induced Pluripotent Stem Cell-Derived Endothelial Cells. Int J Mol Sci 2022/23:8507. doi: 10.3390/ijms23158507.
Emig R, Hoess P, Cai H, Kohl P, Peyronnet R, Weber W, Hörner M. Benchmarking of Cph1 mutants and DrBphP for light-responsive phytochrome-based hydrogels with reversibly adjustable mechanical properties. Adv Biol (Weinh) 2022/6(7):e2000337. doi:10.1002/adbi.202000337.
Zhang YW […] Rettkowski J […] Grün D, Cabezas-Wallscheid N. Hyaluronic acid-GPRC5C signalling promotes dormancy in haematopoietic stem cells. Nat Cell Biol 2022/24(7):1038-1048. doi: 10.1038/s41556-022-00931-x.
Moss R, Wülfers EM, Lewetag R, Hornyik T, Perez-Feliz S, Strohbach T, Menza M, Krafft A, Odening KE, Seemann G. A computational model of rabbit geometry and ECG: Optimizing ventricular activation sequence and APD distribution. PLoS One 2022/17(6):e0270559. doi: 10.1371/journal.pone.0270559.
Barco S, Voci D, Held U, Sebastian T, Bingisser R, Colucci G, Duerschmied D, Frenk A, Gerber B, Götschi A, Konstantinides SV, Mach F, Robert-Ebadi H, Rosemann T, Simon NR, Spechbach H, Spirk D, Stortecky S, Vaisnora L, Righini M, Kucher N; OVID investigators. Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet Haematol 2022/9:e585-e593.
doi: 10.1016/S2352-3026(22)00175-2.
Rosenkaimer SL, Winter L, Sieburg T, Maier S, Mavratzas A, Hofmann WK, Akin I, Duerschmied D, Hofheinz RD, Hohneck A. Diagnostic Value of sST2, VCAM-1, and Adiponectin in Patients with Breast Cancer to Predict Anti-Tumour Treatment-Related Cardiac Events: A Pilot Study. Oncol Res Treat 2022/45:598-607. doi: 10.1159/000525683.
Wiedmann F, De Simone R, Rose P, Karck M, Gorenflo M, Frey N, Schmidt C. Case report of an S-ICD implantation for secondary prevention in a patient with complex congenital heart disease, dextrocardia, and situs solitus. Eur Heart J Case Rep 2022/6:ytac253. doi: 10.1093/ehjcr/ytac253.
Wiedmann F […] Kraft M, Paasche A […] Schmidt C. Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy. Cardiovasc Res 2022/118(7):1728-1741. doi: 10.1093/cvr/cvab177.
Ngo V, Fleischmann BK, Jung M, Hein L, Lother A. Histone deacetylase 6 inhibitor JS28 prevents pathological gene expression in cardiac myocytes. J Am Heart Assoc 2022/11:e025857. doi: 10.1161/JAHA.122.025857.
Gauchel N, Rieder M, Krauel K, Goller I, Jeserich M, Salzer U, Venhoff AC, Baldus N, Pollmeier L, Wirth L, Kern W, Rieg S, Busch HJ, Hofmann M, Bode C, Duerschmied D, Lother A, Heger LA. Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease. J Thromb Thrombolysis 2022/53:788-797. doi: 10.1007/s11239-021-02617-x.
Sanchez O, Charles-Nelson A […] Binder H […] Duerschmied D […] Meyer G. Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial. Thromb Haemost 2022/122:857-866. doi: 10.1055/a-1653-4699.
Heger LA, Elsen N, Rieder M, Gauchel N, Sommerwerck U, Bode C, Duerschmied D, Oette M, Ahrens I. Clinical analysis on diagnostic accuracy of Bosch Vivalytic SARS-CoV-2 point-of-care test and evaluation of cycle threshold at admission for COVID-19 risk assessment. BMC Infect Dis 2022/22:486. doi: 10.1186/s12879-022-07447-7.
Lother A, Jaisser F, Wenzel UO. Emerging fields for therapeutic targeting of the aldosterone-mineralocorticoid receptor signaling pathway. Br J Pharmacol 2022/179:3099-3102. doi: 10.1111/bph.15808.
Shvedunova M, Akhtar A. Modulation of cellular processes by histone and non-histone acetylation. Nat Rev Mol Cell Biol 2022/23(5):329-349. doi: 10.1038/s41580-021-00441-y.
Akbil B, Meyer T […] Lother A, Duerschmied D […]; Pa-COVID study Group […] Goffinet C. Early and rapid identification of COVID-19 patients with neutralizing type I interferon auto-antibodies. J Clin Immunol 2022/ahead of print. doi: 10.1007/s10875-022-01252-2.
Greiner J, Sankarankutty AC, Seidel T, Sachse FB. Confocal microscopy-based estimation of intracellular conductivities in myocardium for modeling of the normal and infarcted heart. Comput Biol Med 2022/146:105579. doi: 10.1016/j.compbiomed.2022.105579.
